MedTrace Logo

Expert Consensus on the Use of Isotretinoin in Rejuvenation: A Delphi Study

NCT07296536 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-12-22

No results posted yet for this study

Summary

This expert consensus project explores the role of low-dose isotretinoin as a rejuvenative and preventive strategy for photoaging and sebaceous-driven skin changes. While isotretinoin is traditionally used for acne, increasing clinical experience suggests that carefully selected micro-dose and low-dose regimens may improve skin texture, pore size, sebaceous activity, and overall skin quality, with potential benefits in skin aging and maintenance rejuvenation programs.

Conditions

  • Isotretinoin
  • Isotretinoin Adverse Reaction
  • Rejuvenation

Sponsors & Collaborators

  • Venus Research Center

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-25
Primary Completion
2027-06-01
Completion
2027-09-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07296536 on ClinicalTrials.gov